Robert Seder

Member, Scientific Advisory Board at Argos Therapeutics, Inc.

Robert Seder

Robert Seder

Member, Scientific Advisory Board at Argos Therapeutics, Inc.

Biography

Dr. Seder earned his MD at Tufts University and is currently chief of the cellular immunology section, Vaccine Research Center, at the National Institute of Allergy and Infectious Diseases, National Institutes of Health. He has also served as chief of the clinical immunology section in the laboratory of clinical investigation, part of the NIAID Division of Intramural Research. Dr. Seder’s research is focused on developing and understanding how vaccines mediate protective antibody and T cell immunity against HIV, malaria and tuberculosis.

Overview
RelSci Relationships

398

Number of Boards

2

Relationships
RelSci Relationships are individuals Robert Seder likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chairman, President & Chief Executive Officer at UbiVac LLC

Relationship likelihood: Strong

Co-Director, Cancer Immunotherapy Program at Columbia University Medical Center

Relationship likelihood: Strong

Founder at Agensys, Inc.

Relationship likelihood: Strong

Chief of Strategy, Business Development & Outreach at Roswell Park Comprehensive Cancer Center

Relationship likelihood: Strong

Member, Scientific Advisory Board at Argos Therapeutics, Inc.

Relationship likelihood: Strong

Chief Restructuring Officer at Argos Therapeutics, Inc.

Relationship likelihood: Average

Chief Operating Officer at Argos Therapeutics, Inc.

Relationship likelihood: Average

Chief Executive Officer at Veset International Ltd.

Relationship likelihood: Average

Chief Executive Officer & Director at Novadip Biosciences SA

Relationship likelihood: Average

Adjunct Professor of Business Management & Marketing at The University of North Carolina at Wilmington

Relationship likelihood: Average

In The News
Targeted News Service
February 9, 2019
U.S. Patents Awarded to Inventors in Maryland (Feb. 9)
Los Angeles Times (6+ months)
August 9, 2013
Test of malaria vaccine is encouraging
Paths to Robert Seder
Potential Connections via
Relationship Science
You
Robert Seder
Member, Scientific Advisory Board at Argos Therapeutics, Inc.
Family Members
Parent-In-Law
Founder, Chairman & Co-Chief Investment Officer at Caravel Management LLC - New York

Caravel Management focuses on investments in invest in publicly traded equities in emerging markets and frontier markets that are demonstrating signs of change, reform and growth. The Caravel Fund is dedicated to the non-BRIC (Brazil, Russia, India and China) emerging and frontier universe and maintains a genuinely long-term performance horizon.Caravel Management seeks to deliver superior investment performance by building a concentrated, high conviction portfolio, taking a long-term investment view and maintaining a rigorous fundamental analysis framework that combines top-down and bottom-up analysis. The firm focuses on business fundamentals, valuation and earnings growth. Through portfolio construction and diversification of investments across countries, currencies, and industries, Caravel Management seeks to provide the optimal risk-adjusted return for investors.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Robert Seder. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Robert Seder's profile does not indicate a business or promotional relationship of any kind between RelSci and Robert Seder.